PFIZER/WARNER-LAMBERT LIPITOR AGREEMENT MAY LEAD TO MORE DEALS BETWEEN FIRMS, PFIZER SAYS; COMPRESSED INTERNATIONAL LAUNCH SCHEDULE POSES CHALLENGES
Executive Summary
The compressed schedule for international launches gives pharmaceutical companies less of a "learning curve" for rolling out new products, Pfizer Exec VP Henry McKinnell, PhD, told a Bear Stearns health care conference in New York City Sept. 11.